Nitasha Kumar1, Ann Chahroudi, Guido Silvestri. 1. aYerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA bEmory Vaccine Center, Emory University, Atlanta, GA 30329; USA cDepartment of Pediatrics, Emory University School of Medicine, Atlanta, GA 30329, USA dDepartment of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30329, USA.
Abstract
PURPOSE OF REVIEW: The introduction of effective antiretroviral therapy (ART) has transformed HIV infection from a deadly to a chronic infection. Despite its successes in reducing mortality, ART fails to cure HIV allowing HIV to persist in vivo. HIV persistence under ART is thought to be mediated by a combination of latent infection of long-lived cells, homeostatic proliferation of latently infected cells, anatomic sanctuaries, and low-level virus replication. To understand the contribution of specific cell types and anatomic sites to virus persistence in vivo animal models are necessary. RECENT FINDINGS: The advancements in ART and our understanding of animal models have facilitated the development of models of HIV persistence in nonhuman primates and mice. Simian immunodeficiency virus (SIV) or simian/HIV infection (SHIV) of rhesus and pigtail macaques followed by effective ART represents the most faithful animal model of HIV persistence. HIV infection of humanized mice also provides a useful model for answering specific questions regarding virus persistence in a uniquely mutable system. SUMMARY: In this review, we describe the most recent findings using animal models of HIV persistence. We will first describe the important aspects of HIV infection that SIV/SHIV infection of nonhuman primates are able to recapitulate, then we will discuss some recent studies that have used these models to understand viral persistence.
PURPOSE OF REVIEW: The introduction of effective antiretroviral therapy (ART) has transformed HIV infection from a deadly to a chronic infection. Despite its successes in reducing mortality, ART fails to cure HIV allowing HIV to persist in vivo. HIV persistence under ART is thought to be mediated by a combination of latent infection of long-lived cells, homeostatic proliferation of latently infected cells, anatomic sanctuaries, and low-level virus replication. To understand the contribution of specific cell types and anatomic sites to virus persistence in vivo animal models are necessary. RECENT FINDINGS: The advancements in ART and our understanding of animal models have facilitated the development of models of HIV persistence in nonhuman primates and mice. Simian immunodeficiency virus (SIV) or simian/HIV infection (SHIV) of rhesus and pigtail macaques followed by effective ART represents the most faithful animal model of HIV persistence. HIV infection of humanized mice also provides a useful model for answering specific questions regarding virus persistence in a uniquely mutable system. SUMMARY: In this review, we describe the most recent findings using animal models of HIV persistence. We will first describe the important aspects of HIV infection that SIV/SHIV infection of nonhuman primates are able to recapitulate, then we will discuss some recent studies that have used these models to understand viral persistence.
Authors: Adam M Spivak; Adriana Andrade; Evelyn Eisele; Rebecca Hoh; Peter Bacchetti; Namandjé N Bumpus; Fatemeh Emad; Robert Buckheit; Elinore F McCance-Katz; Jun Lai; Margene Kennedy; Geetanjali Chander; Robert F Siliciano; Janet D Siliciano; Steven G Deeks Journal: Clin Infect Dis Date: 2013-12-12 Impact factor: 9.079
Authors: Thomas A Rasmussen; Martin Tolstrup; Christel R Brinkmann; Rikke Olesen; Christian Erikstrup; Ajantha Solomon; Anni Winckelmann; Sarah Palmer; Charles Dinarello; Maria Buzon; Mathias Lichterfeld; Sharon R Lewin; Lars Østergaard; Ole S Søgaard Journal: Lancet HIV Date: 2014-09-15 Impact factor: 12.767
Authors: Maria M Bednar; Christa Buckheit Sturdevant; Lauren A Tompkins; Kathryn Twigg Arrildt; Elena Dukhovlinova; Laura P Kincer; Ronald Swanstrom Journal: Curr HIV/AIDS Rep Date: 2015-06 Impact factor: 5.071
Authors: Nicolas Chomont; Mohamed El-Far; Petronela Ancuta; Lydie Trautmann; Francesco A Procopio; Bader Yassine-Diab; Geneviève Boucher; Mohamed-Rachid Boulassel; Georges Ghattas; Jason M Brenchley; Timothy W Schacker; Brenna J Hill; Daniel C Douek; Jean-Pierre Routy; Elias K Haddad; Rafick-Pierre Sékaly Journal: Nat Med Date: 2009-06-21 Impact factor: 53.440
Authors: Paul W Denton; Rikke Olesen; Shailesh K Choudhary; Nancy M Archin; Angela Wahl; Michael D Swanson; Morgan Chateau; Tomonori Nochi; John F Krisko; Rae Ann Spagnuolo; David M Margolis; J Victor Garcia Journal: J Virol Date: 2011-10-19 Impact factor: 5.103
Authors: Suresh Pallikkuth; Luca Micci; Zachary S Ende; Robin I Iriele; Barbara Cervasi; Benton Lawson; Colleen S McGary; Kenneth A Rogers; James G Else; Guido Silvestri; Kirk Easley; Jacob D Estes; Francois Villinger; Savita Pahwa; Mirko Paiardini Journal: PLoS Pathog Date: 2013-07-04 Impact factor: 6.823
Authors: Gregory M Laird; Evelyn E Eisele; S Alireza Rabi; Jun Lai; Stanley Chioma; Joel N Blankson; Janet D Siliciano; Robert F Siliciano Journal: PLoS Pathog Date: 2013-05-30 Impact factor: 6.823
Authors: Sirish Khanal; Christine M Fennessey; Sean P O'Brien; Abigail Thorpe; Carolyn Reid; Taina T Immonen; Rodman Smith; Julian W Bess; Adrienne E Swanstrom; Gregory Q Del Prete; Miles P Davenport; Afam A Okoye; Louis J Picker; Jeffrey D Lifson; Brandon F Keele Journal: J Virol Date: 2019-12-12 Impact factor: 5.103
Authors: David Palesch; Steven E Bosinger; Maud Mavigner; James M Billingsley; Cameron Mattingly; Diane G Carnathan; Mirko Paiardini; Ann Chahroudi; Thomas H Vanderford; Guido Silvestri Journal: J Virol Date: 2018-06-29 Impact factor: 5.103
Authors: Lucio Gama; Celina Abreu; Erin N Shirk; Suzanne E Queen; Sarah E Beck; Kelly A Metcalf Pate; Brandon T Bullock; M Christine Zink; Joseph L Mankowski; Janice E Clements Journal: Curr Top Microbiol Immunol Date: 2018 Impact factor: 4.291
Authors: Celina Abreu; Erin N Shirk; Suzanne E Queen; Sarah E Beck; Lisa M Mangus; Kelly A M Pate; Joseph L Mankowski; Lucio Gama; Janice E Clements Journal: AIDS Date: 2019-12-01 Impact factor: 4.177
Authors: Nitasha A Kumar; Julia B McBrien; Diane G Carnathan; Maud Mavigner; Cameron Mattingly; Erick R White; Federico Viviano; Steve E Bosinger; Ann Chahroudi; Guido Silvestri; Mirko Paiardini; Thomas H Vanderford Journal: J Virol Date: 2018-10-29 Impact factor: 5.103
Authors: Hannah S Sperber; Padma Priya Togarrati; Kyle A Raymond; Mohamed S Bouzidi; Renata Gilfanova; Alan G Gutierrez; Marcus O Muench; Satish K Pillai Journal: FASEB J Date: 2020-09-09 Impact factor: 5.191